In conclusion, any investigation into serum MACC1 in breast cancer has the potential to uncover fresh information on how highly circulating MACC1 in liquid biopsy (non-invasive) can be used to predict the progression and formation of metastases in breast cancer (e.g., patient blood). This evidence concerns the gene MACC1 and breast cancer.